Wie hoch ist der Preis für Organicell Regenerative Medicine, Inc. (OCEL)

Preis für Organicell Regenerative Medicine, Inc. (OCEL) ist $1.77

Wie hoch ist die Marktkapitalisierung für Organicell Regenerative Medicine, Inc. (OCEL)

Marktkapitalisierung für Organicell Regenerative Medicine, Inc. (OCEL) ist $12.89M

Organicell Regenerative Medicine, Inc. (OCEL) Ausstehende Aktien

Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regenerative service providers. The company maintains key research collaborations: one with the Centers for Disease Control and Prevention (CDC) to explore Zofin's anti-inflammatory and anti-infective capabilities in experimental influenza models, and another with Oklahoma State University to assess Zofin's potential in treating severe respiratory illnesses stemming from viruses with pandemic risk. Founded in 2011, this Miami, Florida-based company initially operated as Biotech Products Services and Research, Inc. It adopted its current name, Organicell Regenerative Medicine, Inc., in June 2018.

Jahr	Ausstehende Aktien	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Ausstehende Aktien

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Ausstehende Aktien	Unterschied	Land
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
CSL Limited CSL.AX	483.58M	-	AU
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR

Unternehmen

Ausstehende Aktien

Unterschied

Land